Oracles Debt Burden Raises Concerns Amid AI Data Center Push AGBK Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Innovent Biologics and Pfizer Announce Landmark Drug Deal Valued at Up to 105 Billion LARK Q1 2026 Earnings EPS of 083 Reported Stock Declines Slightly Minerva Neurosciences Q1 2026 Earnings EPS Misses Street Estimates Stock Gains on Pipeline Optimism IonQ Q1 2026 Earnings EPS Surprise Beats Estimates as Stock Jumps 12 CIG Q1 2026 Earnings EPS Beats Estimates But Stock Slips 26 SYM Q1 2026 Earnings EPS Misses Estimates Shares Gain on Strategic Progress MTH Q1 2026 Earnings EPS Misses Estimates Stock Inches Higher ATKR Q1 2026 Earnings Strong EPS Beat Signals Resilient Operations